시장보고서
상품코드
1469126

MRI 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 자기장 강도별, 유형별, 아키텍처별, 용도별, 최종사용자별, 지역별, 경쟁사별(2019-2029년)

MRI Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Field Strength, By Type, By Architecture, By Application, By End User, By Region and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 181 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 MRI 시장 규모는 2023년 52억 5,000만 달러에 달할 것으로 예상되며, 2029년까지 연평균 5.25%의 CAGR로 예측 기간 동안 안정적인 성장을 이룰 것으로 예상됩니다. 현대 의료에서 자기공명영상(MRI)은 의료 진단 및 연구에 혁명을 가져온 정밀한 진단 영상을 가능하게 하는 핵심 기술입니다.

세계 MRI 시장은 기술 발전, 만성 질환의 증가, 이미지 품질 향상, 스캔 시간 단축, 환자 편의성 향상 등 MRI 기술의 비약적인 발전에 힘입어 수년 동안 큰 성장을 거듭해 왔습니다. 고자기장 MRI, 개방형 MRI 시스템, 뇌 활동 연구를 위한 기능적 MRI(fMRI)와 같은 혁신은 MRI의 범위와 응용을 확대했습니다.

심혈관 질환, 암, 신경 질환과 같은 만성 질환은 효과적인 치료 계획을 세우기 위해 정확한 조기 진단이 필요합니다. 연조직, 장기, 혈관의 상세한 영상을 제공하는 MRI의 능력은 이러한 질환의 진단과 관리에 필수적이며, MRI는 전리방사선에 노출되지 않는 비침습적이기 때문에 환자와 의료진 모두 선호하고 있습니다. 이 때문에 CT 스캔이나 엑스레이와 같은 기존 영상 진단 방법보다 MRI 검사에 대한 수요가 증가하고 있습니다. 전 세계적으로 고령화가 진행됨에 따라 관절염, 치매, 뇌졸중과 같은 노화 관련 질환의 유병률이 증가하고 있습니다. 해부학적 구조와 병리학적 구조의 미세한 변화를 감지하는 MRI의 민감도는 노인 의료 분야에서 MRI의 채택 확대에 기여하고 있습니다. 특히 선진국의 의료비 지출 증가는 MRI 시스템과 같은 첨단 의료 기술에 대한 접근을 용이하게 하고 있습니다. 신흥국들도 의료 인프라에 대한 투자를 늘리고 있어 시장 성장을 더욱 촉진하고 있습니다.

주요 시장 촉진요인

만성질환의 유병률 증가가 세계 MRI 시장을 주도

연구 및 임상시험의 새로운 응용 분야가 MRI 세계 시장을 주도

주요 시장 과제

MRI 시스템의 높은 비용

유지보수 및 운영비용

주요 시장 동향

기술의 발전

부문별 인사이트

자기장 강도별 인사이트

용도별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 세계의 MRI 시장에 대한 COVID-19의 영향

제4장 주요 요약

제5장 고객의 소리

제6장 세계의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별(고자장 MRI 시스템(1.5t MRI 시스템, 3t MRI 시스템), 저중자장 MRI 시스템(1.5 t미만), 초고자장 MRI 시스템(4 t이상))
    • 유형별(고정형, 이동형)
    • 아키텍처별(클로즈드 MRI 시스템, 오픈 MRI 시스템)
    • 용도별(뇌·신경, 종양, 척추·근골격, 복부, 심장, 기타)
    • 최종사용자별(병원, 영상 진단 센터, 외래 수술 센터, 기타)
    • 기업별(2023년)
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별
    • 유형별
    • 아키텍처별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제8장 유럽의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별
    • 유형별
    • 아키텍처별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별
    • 유형별
    • 아키텍처별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별
    • 유형별
    • 아키텍처별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 MRI 시장 전망

  • 시장 규모 예측
    • 금액 수량 기준
  • 시장 점유율 예측
    • 자장 강도별
    • 유형별
    • 아키텍처별
    • 용도별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

  • 인수합병
  • 제품 발매
  • 최근의 동향

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 상황

  • GE Healthcare Technologies, Inc.
  • Aurora Imaging Technologies, Inc.
  • Sanrad Medical Systems Pvt ltd.
  • Aspect Imaging
  • Esaote SpA
  • Fonar Corporation
  • Hitachi Ltd
  • Neusoft Medical Systems Co. Ltd
  • Koninklijke Philips NV
  • Siemens Healthcare GmbH
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Hologic, Inc.
  • Nordion Inc.
  • United Imaging Healthcare Co., Ltd

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

ksm 24.05.02

Global MRI Marketwas valued at USD 5.25 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In the landscape of modern healthcare, Magnetic Resonance Imaging (MRI) stands as a cornerstone technology, enabling precise diagnostic imaging that has revolutionized medical diagnostics and research. The global MRI market has experienced significant growth over the years, driven by technological advancements, the increasing prevalence of chronic diseases, and the rise in MRI technology has evolved dramatically, with improvements in image quality, faster scanning times, and enhanced patient comfort. Innovations such as high-field MRI, open MRI systems, and functional MRI (fMRI) for studying brain activity have expanded the scope and applications of MRI.

Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions require accurate and early diagnosis for effective treatment planning. MRI's ability to provide detailed images of soft tissues, organs, and blood vessels has made it indispensable in the diagnosis and management of these conditions. MRI's non-invasive nature, with no exposure to ionizing radiation, makes it a preferred choice for both patients and healthcare providers. This has driven demand for MRI procedures over traditional imaging modalities like CT scans and X-rays. As populations age worldwide, the prevalence of age-related conditions such as arthritis, dementia, and stroke has risen. MRI's sensitivity in detecting subtle changes in anatomy and pathology has contributed to its growing adoption in geriatric care. Higher healthcare spending, especially in developed regions, has facilitated greater access to advanced medical technologies like MRI systems. Emerging economies are also investing in healthcare infrastructure, further propelling market growth.

Key Market Drivers

Growing Prevalence of Chronic Diseases is Driving the Global MRI Market

The global healthcare landscape is witnessing a profound shift driven by the rising incidence of chronic diseases worldwide. This epidemiological trend has significantly contributed to the increased demand for advanced diagnostic imaging technologies, particularly Magnetic Resonance Imaging (MRI). MRI plays a pivotal role in the early detection, accurate diagnosis, and effective management of various chronic conditions, thereby driving the expansion of the global MRI market. Chronic diseases, characterized by their prolonged duration and generally slow progression, are now the leading cause of morbidity and mortality globally. Conditions such as cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, and neurological disorders are becoming more prevalent, primarily due to aging populations, unhealthy lifestyles, and environmental factors. The burden of chronic illnesses is particularly pronounced in low- and middle-income countries, where healthcare systems often struggle to cope with the growing demand for diagnosis and treatment.

MRI has emerged as a cornerstone of diagnostic imaging for a wide range of chronic diseases. Its non-invasive nature and ability to produce detailed, high-resolution images of soft tissues make it indispensable for clinicians in the assessment and monitoring of chronic conditions. MRI is crucial in oncology for detecting tumors, evaluating disease extent, staging cancers, and monitoring treatment response. Advanced MRI techniques like diffusion-weighted imaging (DWI) and magnetic resonance spectroscopy (MRS) aid in tumor characterization and guide therapeutic decisions. MRI is employed for assessing cardiac structure and function, detecting myocardial infarction, evaluating congenital heart abnormalities, and diagnosing conditions like heart failure and cardiomyopathies. MRI is the gold standard for imaging the brain and spinal cord, facilitating the diagnosis of stroke, multiple sclerosis, Alzheimer's disease, brain tumors, and other neurological conditions. MRI is used extensively in orthopedics to assess joint abnormalities, ligament and tendon injuries, spinal disorders, and sports-related injuries. MRI is valuable in diagnosing liver diseases, pancreatic disorders, pelvic abnormalities, and gastrointestinal conditions.

Emerging Applications in Research and Clinical Trials is Driving the Global MRI Market

The integration of MRI into research and clinical trials is revolutionizing how medical discoveries are made and therapies are developed. MRI's unique capabilities to visualize soft tissues, organs, and physiological processes in real-time have opened doors to a multitude of applications that were previously challenging or impossible to achieve with other imaging modalities. Functional MRI (fMRI) enables researchers to map brain activity by detecting changes in blood flow and oxygenation levels associated with neuronal activity. This technique is pivotal in understanding brain function, mapping neural pathways, and investigating neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. The insights gained from fMRI studies are crucial for developing targeted treatments and interventions.

Diffusion MRI is instrumental in studying the microstructure of white matter fibers in the brain. It provides valuable information about tissue integrity, connectivity, and neuroplasticity. Researchers leverage diffusion MRI to study conditions like multiple sclerosis, stroke, and traumatic brain injury, leading to advancements in treatment strategies and rehabilitation protocols. MRI biomarkers, including quantitative measures derived from imaging data, play a pivotal role in disease monitoring and treatment response assessment. In clinical trials, MRI biomarkers serve as objective measures of therapeutic efficacy, aiding in the development and validation of new drugs and therapies across various disease areas such as oncology, cardiology, and rheumatology.

Recent advances in molecular imaging techniques have enabled the visualization of specific molecular targets using MRI contrast agents. Molecular MRI facilitates the non-invasive detection of biomarkers associated with disease processes, paving the way for personalized medicine and targeted therapies. This approach holds promise for improving patient stratification and optimizing treatment outcomes. MRI-guided interventions combine real-time imaging with minimally invasive procedures, enabling precise targeting of pathological tissues while minimizing damage to healthy surrounding structures. MRI-guided interventions are employed in cancer therapy, pain management, and neurosurgery, enhancing treatment accuracy and patient safety.

The integration of MRI into research and clinical trials is a key driver of growth in the global MRI market. Pharmaceutical companies, academic institutions, and healthcare providers are increasingly leveraging MRI to accelerate drug development, validate therapeutic targets, and refine treatment protocols. The demand for advanced MRI systems capable of supporting these emerging applications is fueling market expansion. Furthermore, regulatory agencies are recognizing the value of MRI-derived data in decision-making processes, encouraging greater adoption of MRI technologies in clinical research. As MRI continues to evolve with cutting-edge innovations such as high-field strength magnets, functional imaging techniques, and artificial intelligence-driven analytics, its role in shaping the future of healthcare research and personalized medicine will only continue to grow.

Key Market Challenges

High Cost of MRI Systems

One of the primary challenges hindering the widespread adoption of MRI technology is the high upfront cost associated with MRI systems. The initial investment required to acquire and maintain MRI equipment is substantial, making it prohibitive for many healthcare facilities, especially in resource-constrained settings. The high cost of MRI systems can deter smaller hospitals and clinics from investing in this technology, limiting patient access to advanced imaging services.

Maintenance and Operational Expenses

In addition to the initial purchase cost, MRI systems require significant ongoing maintenance and operational expenses. Regular servicing, software updates, and replacement parts can add to the overall cost of ownership. Healthcare providers often face budgetary constraints when allocating resources for MRI maintenance, impacting the efficiency and uptime of MRI machines.

Key Market Trends

Technological Advancements

One of the most notable advancements in MRI technology is the development of high-field MRI systems, characterized by stronger magnetic fields (1.5 Tesla and above). High-field MRI machines offer superior image resolution, enabling radiologists to visualize fine anatomical details with greater clarity. This increased sensitivity is particularly beneficial for detecting subtle abnormalities, such as small tumors or microvascular changes, improving diagnostic accuracy and confidence. Modern MRI systems are equipped with advanced radiofrequency coil arrays that capture signals from the patient's body more efficiently. Multi-channel coil designs optimize signal reception, leading to enhanced image quality and faster scan times. These coil arrays can be tailored to specific imaging needs, facilitating imaging of various anatomical regions with optimal sensitivity and spatial coverage.

Gradient coils play a crucial role in spatially encoding MR signals and enabling rapid image acquisition. Recent advancements in gradient coil technology have led to the development of stronger and faster gradients, enabling accelerated imaging techniques such as echo planar imaging (EPI) and diffusion-weighted imaging (DWI). Improved gradient performance contributes to shorter scan times, reducing patient discomfort and increasing throughput in clinical settings. Parallel imaging techniques leverage multi-channel coil arrays to acquire multiple lines of k-space simultaneously, accelerating image acquisition without compromising spatial resolution. Additionally, advanced pulse sequences, such as turbo spin-echo (TSE) and fast spin-echo (FSE), allow for rapid data acquisition and reduced motion artifacts. These accelerated imaging methods enhance workflow efficiency and patient throughput, making MRI more accessible and convenient.

Technological advancements have expanded the clinical utility of MRI beyond anatomical imaging. Functional MRI (fMRI) techniques visualize changes in blood flow and oxygenation levels in response to neural activity, enabling mapping of brain function. MR spectroscopy measures metabolite concentrations within tissues, providing insights into biochemical processes. These functional imaging modalities have revolutionized neuroscience and neurosurgical planning, enhancing our understanding of brain disorders. Software innovations and AI-driven algorithms are transforming MRI data analysis and interpretation. AI technologies enable automated image reconstruction, motion correction, and quantitative analysis, streamlining workflows and reducing the burden on radiologists. AI-based image processing techniques enhance diagnostic accuracy and enable personalized medicine approaches tailored to individual patient characteristics. Technological advancements in MRI have prioritized patient comfort and safety. Innovations such as wide-bore MRI systems and noise reduction techniques mitigate claustrophobia and acoustic discomfort during scans. Moreover, real-time motion tracking and adaptive imaging strategies minimize motion artifacts, ensuring high-quality diagnostic results even in challenging patient populations. Emerging MRI applications, including cardiac MRI, musculoskeletal imaging, and molecular imaging, are expanding clinical indications and driving market growth. Tailored MRI sequences and contrast agents enable precise characterization of tissue properties, facilitating early disease detection and treatment monitoring across various medical specialties.

Segmental Insights

Field Strength Insights

Basedon the category of Field Strength, High-Field MRI Systems emerged as the dominant segment in the global market for MRI in 2023.High-Field MRI systems typically operate at field strengths of 1.5 Tesla (T) and above, offering superior imaging resolution compared to lower-field systems. Higher field strengths enable better visualization of anatomical structures and pathological changes, making them ideal for detailed diagnostic imaging across various medical specialties. The increased signal-to-noise ratio (SNR) in High-Field MRI systems translates into higher diagnostic accuracy. This is particularly important for detecting subtle abnormalities, characterizing soft tissue lesions, and accurately staging diseases. Radiologists and clinicians rely on high-quality images produced by High-Field MRI for confident diagnosis and treatment planning. High-Field MRI systems support a broad spectrum of clinical applications, including neuroimaging, musculoskeletal imaging, cardiovascular imaging, and oncology. The exceptional imaging capabilities of High-Field MRI facilitate advanced techniques such as diffusion-weighted imaging (DWI), functional MRI (fMRI), and magnetic resonance angiography (MRA), enabling comprehensive evaluation of complex medical conditions. With increasing prevalence of chronic diseases and complex medical cases, there is a growing demand for advanced imaging technologies that can provide detailed anatomical and functional information. High-Field MRI meets this demand by offering sophisticated imaging capabilities that aid in early detection, accurate diagnosis, and personalized treatment planning. High-Field MRI systems are favored by research institutions and academic centers for conducting cutting-edge studies in neuroscience, cognitive imaging, and other specialized fields. The high resolution and sensitivity of these systems enable researchers to explore brain function, study disease mechanisms, and develop novel imaging techniques. Continuous advancements in High-Field MRI technology have expanded its clinical utility and improved user experience. Innovations such as parallel imaging, advanced coil designs, and optimized imaging sequences have enhanced the efficiency and diagnostic performance of High-Field MRI systems, further driving their adoption in clinical practice. Major MRI manufacturers have invested heavily in developing High-Field MRI systems, leveraging research and development efforts to push the boundaries of imaging technology. This competitive landscape has led to the introduction of increasingly advanced and versatile High-Field MRI systems, strengthening their position as the preferred choice in the market.

Application Insights

The Brain and Neurological segment is projected to experience rapid growth during the forecast period. Brain and neurological disorders, such as stroke, Alzheimer's disease, multiple sclerosis, brain tumors, and epilepsy, represent a significant global health burden. The prevalence of these conditions is increasing due to aging populations and lifestyle factors, leading to a growing demand for advanced imaging techniques like MRI for accurate diagnosis and monitoring. MRI's superior soft tissue contrast and multiplanar imaging capabilities make it particularly effective for assessing brain anatomy and detecting abnormalities. MRI can visualize intricate structures within the brain, such as white matter, gray matter, blood vessels, and the spinal cord, providing detailed information without exposing patients to ionizing radiation. Neurological conditions often require precise diagnosis and treatment planning. MRI enables clinicians to identify subtle changes in brain structure and function, aiding in early detection, differential diagnosis, and personalized treatment strategies. This capability is crucial for optimizing patient outcomes and improving quality of life. Functional MRI (fMRI) techniques have revolutionized the study of brain function by mapping neuronal activity and connectivity in real-time. fMRI is instrumental in research and clinical settings for understanding brain physiology, cognitive processes, and neurological disorders. The integration of fMRI with traditional structural MRI enhances diagnostic capabilities and therapeutic interventions. The neuroscience field is witnessing a surge in research initiatives and clinical trials focused on understanding brain disorders and developing novel therapies. MRI plays a pivotal role in neuroimaging studies, providing valuable insights into disease mechanisms, treatment response, and biomarker discovery. This increased research activity drives the demand for MRI systems specialized for neurological applications.

Regional Insights

Asia Pacific emerged as the dominant region in the global MRI market in 2023, holding the largest market share in terms of value. Asia Pacific has witnessed substantial investments in healthcare infrastructure over the past decade. Rapid economic development in countries like China, India, and Southeast Asian nations has led to increased spending on healthcare facilities and equipment. This expansion has facilitated the establishment of modern hospitals and diagnostic centers equipped with advanced imaging technologies, including MRI systems. The region is experiencing a notable increase in the burden of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions. MRI plays a critical role in the diagnosis, treatment planning, and monitoring of these diseases. As the incidence of chronic illnesses rises, there is a growing demand for advanced imaging services, driving the adoption of MRI technology across Asia Pacific. Improved healthcare awareness among the population, coupled with rising disposable incomes, has led to greater demand for high-quality medical services in Asia Pacific. Patients and healthcare providers increasingly prefer advanced diagnostic technologies like MRI for accurate and non-invasive diagnosis. This demand has spurred the expansion of MRI services in urban centers and tertiary healthcare facilities. Asia Pacific has embraced technological advancements in healthcare, including MRI technology. The region has become a hub for manufacturing and innovation in medical devices, leading to the availability of advanced MRI systems tailored to local needs. Continuous improvements in MRI technology, such as higher field strengths, faster scan times, and enhanced imaging capabilities, have accelerated the adoption of MRI across the region. Governments in Asia Pacific have prioritized healthcare infrastructure development and investment in medical technology. Policies aimed at improving healthcare access, enhancing diagnostic capabilities, and reducing disease burden have encouraged the adoption of MRI technology. Subsidies, grants, and incentives for healthcare providers to procure MRI equipment have further fueled market growth.

Key Market Players

GE HealthcareTechnologies, Inc.

Aurora Imaging Technologies, Inc.

Sanrad Medical Systems Pvt ltd.

Aspect Imaging

Esaote SpA

Fonar Corporation

Hitachi Ltd

Neusoft Medical Systems Co. Ltd

Koninklijke Philips NV

Siemens Healthcare GmbH

Canon Medical Systems Corporation

Mindray Medical International Limited

Hologic, Inc.

Nordion Inc.

United Imaging Healthcare Co., Ltd

Report Scope:

In this report, Global MRI Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

MRI Market, By Field Strength:

High-Field MRI Systems

Low-To-Mid-Field MRI Systems

Very-High-Field MRI Systems

MRI Market, By Type:

Fixed

Mobile

MRI Market, By Architecture:

Closed MRI Systems

Open MRI Systems

MRI Market, By Application:

Brain and Neurological

Oncology

Spine and Musculoskeletal

Abdominal

Cardiac

Others

MRI Market, By End User:

Hospitals

Imaging Centers

Ambulatory Surgical Centers

Others

MRI Market, By Region:

Asia Pacific

China

India

Japan

South Korea

Australia

Europe

France

Germany

United Kingdom

Italy

Spain

North America

United States

Mexico

Canada

South America

Brazil

Argentina

Colombia

Middle East and Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the MRI Market.

Available Customizations:

Global MRI marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Impact of COVID-19 on Global MRI Market

4.Executive Summary

  • 4.1.Overview of the Market
  • 4.2.Overview of Key Market Segmentations
  • 4.3.Overview of Key Market Players
  • 4.4.Overview of Key Regions/Countries
  • 4.5.Overview of Market Drivers, Challenges, and Trends

5. Voice of Customer

6.Global MRI Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value Volume
  • 6.2.Market Share Forecast
    • 6.2.1.By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-To-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above))
    • 6.2.2.By Type (Fixed, Mobile)
    • 6.2.3.By Architecture (Closed MRI Systems and Open MRI Systems)
    • 6.2.4.By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others)
    • 6.2.5.By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others)
    • 6.2.6.By Company (2023)
    • 6.2.7.By Region
  • 6.3.Product Market Map

7.Asia-Pacific MRI Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value Volume
  • 7.2.Market Share Forecast
    • 7.2.1.By Field Strength
    • 7.2.2.By Type
    • 7.2.3.By Architecture
    • 7.2.4.By Application
    • 7.2.5.By End User
    • 7.2.6.By Country
  • 7.3.Asia-Pacific: Country Analysis
    • 7.3.1.China MRI Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Field Strength
        • 7.3.1.2.2.By Type
        • 7.3.1.2.3.By Architecture
        • 7.3.1.2.4.By Application
        • 7.3.1.2.5.By End User
    • 7.3.2.India MRI Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Field Strength
        • 7.3.2.2.2.By Type
        • 7.3.2.2.3.By Architecture
        • 7.3.2.2.4.By Application
        • 7.3.2.2.5.By End User
    • 7.3.3.Japan MRI Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Field Strength
        • 7.3.3.2.2.By Type
        • 7.3.3.2.3.By Architecture
        • 7.3.3.2.4.By Application
        • 7.3.3.2.5.By End User
    • 7.3.4.South Korea MRI Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Field Strength
        • 7.3.4.2.2.By Type
        • 7.3.4.2.3.By Architecture
        • 7.3.4.2.4.By Application
        • 7.3.4.2.5.By End User
    • 7.3.5.Australia MRI Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Field Strength
        • 7.3.5.2.2.By Type
        • 7.3.5.2.3.By Architecture
        • 7.3.5.2.4.By Application
        • 7.3.5.2.5.By End User

8.Europe MRI Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value Volume
  • 8.2.Market Share Forecast
    • 8.2.1.By Field Strength
    • 8.2.2.By Type
    • 8.2.3.By Architecture
    • 8.2.4.By Application
    • 8.2.5.By End User
    • 8.2.6.By Country
  • 8.3.Europe: Country Analysis
    • 8.3.1.France MRI Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Field Strength
        • 8.3.1.2.2.By Type
        • 8.3.1.2.3.By Architecture
        • 8.3.1.2.4.By Application
        • 8.3.1.2.5.By End User
    • 8.3.2.Germany MRI Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Field Strength
        • 8.3.2.2.2.By Type
        • 8.3.2.2.3.By Architecture
        • 8.3.2.2.4.By Application
        • 8.3.2.2.5.By End User
    • 8.3.3.United Kingdom MRI Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Field Strength
        • 8.3.3.2.2.By Type
        • 8.3.3.2.3.By Architecture
        • 8.3.3.2.4.By Application
        • 8.3.3.2.5.By End User
    • 8.3.4.Italy MRI Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1.By Field Strength
        • 8.3.4.2.2.By Type
        • 8.3.4.2.3.By Architecture
        • 8.3.4.2.4.By Application
        • 8.3.4.2.5.By End User
    • 8.3.5.Spain MRI Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1.By Field Strength
        • 8.3.5.2.2.By Type
        • 8.3.5.2.3.By Architecture
        • 8.3.5.2.4.By Application
        • 8.3.5.2.5.By End User

9.North America MRI Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value Volume
  • 9.2.Market Share Forecast
    • 9.2.1.By Field Strength
    • 9.2.2.By Type
    • 9.2.3.By Architecture
    • 9.2.4.By Application
    • 9.2.5.By End User
    • 9.2.6.By Country
  • 9.3.North America: Country Analysis
    • 9.3.1.United States MRI Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Field Strength
        • 9.3.1.2.2.By Type
        • 9.3.1.2.3.By Architecture
        • 9.3.1.2.4.By Application
        • 9.3.1.2.5.By End User
    • 9.3.2.Mexico MRI Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Field Strength
        • 9.3.2.2.2.By Type
        • 9.3.2.2.3.By Architecture
        • 9.3.2.2.4.By Application
        • 9.3.2.2.5.By End User
    • 9.3.3.Canada MRI Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Field Strength
        • 9.3.3.2.2.By Type
        • 9.3.3.2.3.By Architecture
        • 9.3.3.2.4.By Application
        • 9.3.3.2.5.By End User

10.South America MRI Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value Volume
  • 10.2.Market Share Forecast
    • 10.2.1.By Field Strength
    • 10.2.2.By Type
    • 10.2.3.By Architecture
    • 10.2.4.By Application
    • 10.2.5.By End User
    • 10.2.6.By Country
  • 10.3.South America: Country Analysis
    • 10.3.1.Brazil MRI Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Field Strength
        • 10.3.1.2.2.By Type
        • 10.3.1.2.3.By Architecture
        • 10.3.1.2.4.By Application
        • 10.3.1.2.5.By End User
    • 10.3.2.Argentina MRI Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Field Strength
        • 10.3.2.2.2.By Type
        • 10.3.2.2.3.By Architecture
        • 10.3.2.2.4.By Application
        • 10.3.2.2.5.By End User
    • 10.3.3.Colombia MRI Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Field Strength
        • 10.3.3.2.2.By Type
        • 10.3.3.2.3.By Architecture
        • 10.3.3.2.4.By Application
        • 10.3.3.2.5.By End User

11.Middle East and Africa MRI Market Outlook

  • 11.1.Market Size Forecast
    • 11.1.1.By Value Volume
  • 11.2.Market Share Forecast
    • 11.2.1.By Field Strength
    • 11.2.2.By Type
    • 11.2.3.By Architecture
    • 11.2.4.By Application
    • 11.2.5.By End User
    • 11.2.6.By Country
  • 11.3.MEA: Country Analysis
    • 11.3.1.South Africa MRI Market Outlook
      • 11.3.1.1.Market Size Forecast
        • 11.3.1.1.1.By Value
      • 11.3.1.2.Market Share Forecast
        • 11.3.1.2.1.By Field Strength
        • 11.3.1.2.2.By Type
        • 11.3.1.2.3.By Architecture
        • 11.3.1.2.4.By Application
        • 11.3.1.2.5.By End User
    • 11.3.2.Saudi Arabia MRI Market Outlook
      • 11.3.2.1.Market Size Forecast
        • 11.3.2.1.1.By Value
      • 11.3.2.2.Market Share Forecast
        • 11.3.2.2.1.By Field Strength
        • 11.3.2.2.2.By Type
        • 11.3.2.2.3.By Architecture
        • 11.3.2.2.4.By Application
        • 11.3.2.2.5.By End User
    • 11.3.3.UAE MRI Market Outlook
      • 11.3.3.1.Market Size Forecast
        • 11.3.3.1.1.By Value
      • 11.3.3.2.Market Share Forecast
        • 11.3.3.2.1.By Field Strength
        • 11.3.3.2.2.By Type
        • 11.3.3.2.3.By Architecture
        • 11.3.3.2.4.By Application
        • 11.3.3.2.5.By End User

12.Market Dynamics

  • 12.1.Drivers
  • 12.2.Challenges

13.Market Trends Developments

  • 13.1.Merger Acquisition (If Any)
  • 13.2.Product Launches (If Any)
  • 13.3.Recent Developments

14.Porters Five Forces Analysis

  • 14.1.Competition in the Industry
  • 14.2.Potential of New Entrants
  • 14.3.Power of Suppliers
  • 14.4.Power of Customers
  • 14.5.Threat of Substitute Products

15.Competitive Landscape

  • 15.1.GE Healthcare Technologies, Inc.
    • 15.1.1.Business Overview
    • 15.1.2.Company Snapshot
    • 15.1.3.Products Services
    • 15.1.4.Financials (As Reported)
    • 15.1.5.Recent Developments
    • 15.1.6.Key Personnel Details
    • 15.1.7.SWOT Analysis
  • 15.2.Aurora Imaging Technologies, Inc.
  • 15.3.Sanrad Medical Systems Pvt ltd.
  • 15.4.Aspect Imaging
  • 15.5.Esaote SpA
  • 15.6.Fonar Corporation
  • 15.7.Hitachi Ltd
  • 15.8.Neusoft Medical Systems Co. Ltd
  • 15.9.Koninklijke Philips NV
  • 15.10.Siemens Healthcare GmbH
  • 15.11.Canon Medical Systems Corporation
  • 15.12.Mindray Medical International Limited
  • 15.13.Hologic, Inc.
  • 15.14.Nordion Inc.
  • 15.15.United Imaging Healthcare Co., Ltd

16.Strategic Recommendations

17. About Us Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제